[print friendly]

naproxen (ALEVE, ANAPROX, NAPROSYN)

• diclofenac (VOLTAREN); etodolac (LODINE); fenoprofen (NALFON); flurbiprofen (ANSAID, OCUFEN); ketoprofen (ORUDIS); meclofenamate (MECLOMEN); mefenamic acid (PONSTEL); nabumetone (RELAFEN); naproxen (ALEVE, ANAPROX, NAPROSYN); oxaprozin (DAYPRO); sulindac (CLINORIL); tolmetin (TOLECTIN)

• Salicylates and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) [hide all summaries]
  The salicylates are used to relieve pain and to reduce fever and inflammation. Aspirin, a nonsteroidal anti-inflammatory drug (NSAID), is the most well-known and frequently used salicylate. Other salicylates discussed on this web site are salsalate and choline and magnesium salicylates.

• Nonsteroidal Anti-Inflammatory Drugs Can Make Blood Pressure Hard to Control [hide all summaries]
  (February 2009)
  Twenty different NSAIDS (nonsteroidal antiinflammatory drugs) are listed in this article that can adversely affect your blood pressure control. The article discusses the way in which this happens and what you can do about it.
• Update on Drugs that Can Cause High Blood Potassium [hide all summaries]
  (December 2008)
  This article lists 68 drugs that can cause high blood potassium (hyperkalemia) that can result in nausea, fatigue, muscle weakness or tingling sensations, as well as heart abnormalities (showing up as an abnormal electrocardiogram). In some cases it can be fatal. If you are taking any of these drugs, be especially careful if you have diabetes or kidney disease. If so, you are at increased risk, and your doctor will have to weigh the risk of giving you these drugs. Also, the older you are, the more likely you are to develop hyperkalemia. Also, make sure you are receiving appropriate laboratory monitoring.
• Drug Induced Psychiatric Symptoms [hide all summaries]
  (October 2002)
  This is the first of a two part series on drug induced psychiatric symptoms that is based on the July 8, 2002 issue of The Medical Letter on Drugs and Therapeutics. Regular readers of Worst Pills, Best Pills News will recognize The Medical Letter as a reference source written for physicians and pharmacists that we often use because of its reputation as an objective and independent source of drug information. The article lists the drugs and their psychiatric adverse effects.
• Alzheimer's Prevention Study Should Be Stopped [hide all summaries]
  (October 2002)
  On September 4, 2002, Public Citizen sent a letter to Health and Human Services (HHS) Secretary Tommy Thompson asking that an Alzheimer’s Disease (AD) prevention trial be immediately stopped and that the patients be provided with information on the risks to which they may already have been exposed.
• Comparative Gastrointestinal (GI) Toxicity of Six Nonsteroidal Anti-inflammatory Drugs (NSAIDs) [hide all summaries]
  (August 2002)
  The British equivalent of our Food and Drug Administration (FDA), in the April 2002 issue of its newsletter Current Problems in Pharmacovigilance, published a ranking of the relative gastrointestinal (GI) toxicity of some of the widely used older nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs are commonly used for acute pain and the treatment of the symptoms of osteo- and rheumatoid arthritis.

• FDA Proposal for Painkiller Warning Is Decades Late [hide all summaries]
  Statement of Dr. Peter Lurie, Deputy Director of Public Citizen’s Health Research Group
• Letter to HHS Secretary Tommy Thompson that raises ethical concerns about the “Alzheimer’s Disease Anti-Inflammatory Prevention Trial” (ADAPT) (HRG Publication #1637) [hide all summaries]
  Because patients are taking drugs without true informed consent, Public Citizen urges the NIA to immediately stop this unethical trial and provide patients already enrolled in the trial with the information previously denied them on lack of plausible benefit as well as the possible health risks.

• Drug Recall for naproxen (ALEVE, ANAPROX, NAPROSYN) reported in September 2, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE) reported in July 29, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE) reported in July 29, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ANAPROX) reported in July 29, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ANAPROX) reported in July 29, 2009 FDA Enforcement Report
• Drug Recall for naproxen (NAPROSYN) reported in July 29, 2009 FDA Enforcement Report
• Drug Recall for naproxen (NAPROSYN) reported in July 29, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE, ANAPROX, NAPROSYN) reported in July 22, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE, ANAPROX, NAPROSYN) reported in July 15, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE, ANAPROX, NAPROSYN) reported in July 8, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE, ANAPROX, NAPROSYN) reported in June 24, 2009 FDA Enforcement Report
• Drug Recall for naproxen (ALEVE, ANAPROX, NAPROSYN) reported in June 17, 2009 FDA Enforcement Report

SHOW secondary search results for naproxen (ALEVE, ANAPROX, NAPROSYN)